Bayer launches online tool to measure cardiovascular risk factors
WHIPPANY, N.J. — In an effort to help consumers understand their risk for life-threatening cardiovascular events, Bayer HealthCare, the makers of Bayer Aspirin, on Monday announced the launch of the ProHeart Path Tool. The ProHeart Path Tool, available on IamProHeart.com, calculates the 5–year risk of a cardiovascular event (heart attack or stroke) based on a risk assessment. The ProHeart Path Tool also provides an individualized summary and action plan with recommended lifestyle changes and tips for lowering the risk of cardiovascular events.
“As a cardiologist, I see many patients come into my office without an understanding of their risk factors for a cardiovascular event. Being proactive about your health, speaking with your physician and understanding your risks are so important,” stated Tracy Stevens, member of the WomenHeart Scientific Advisory Council, WomenHeart’s advisory group of the nation’s leading experts on women’s heart health, and Medical Director of the Saint Luke’s Mid America Heart Institute’s Muriel I. Kauffman Women’s Heart Center. “By using Bayer HealthCare’s ProHeart Path Tool and receiving a personalized action plan, you’ll be equipped for an essential discussion with your physician about how you can best care for your heart.”
Changing specific lifestyle habits, including diet, exercise and smoking can have a large impact on risk factors for cardiovascular events. In fact, smokers are 2-to-4 times more likely to have heart disease. Additionally, an inactive lifestyle is a risk factor for coronary heart disease. Being proactive about your heart health and altering behavior will have life–long positive results.
“Bayer HealthCare has long been dedicated to providing heart health education,” said Fred Duchin, VP marketing analgesics, cough and cold, cardiovascular at Bayer Consumer Care. “And today we are proud to launch the ProHeart Path Tool as we believe it’s a resource that may motivate change in individuals at risk for heart attack or stroke. We hope it provides great value and truly life–saving information.”